TFS Capital’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

TFS Capital’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-17,684	Closed	-$433K	–	1386
2014 Q3	$433K	Buy	+17,684	New	+$359K	0.04%	639
2014 Q2	–	Sell	-132,205	Closed	-$2.65M	–	1667
2014 Q1	$2.65M	Buy	+132,205	New	+$2.56M	0.17%	158
2013 Q4	–	Sell	-83,201	Closed	-$884K	–	1916
2013 Q3	$884K	Sell	83,201 -114,239	-58%	-$999K	0.04%	629
2013 Q2	$1.1M	Buy	+197,440	New	+$1.2M	0.05%	569

Other funds holding ANAC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TFS Capital's ANAC Position: Q4 2014 in Review

TFS Capital sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2014, closing a stake of 17,684 shares — an estimated $433K sold.

TFS Capital first reported a position in ANAC in Q2 2013 and held it in 4 quarters. The position peaked at $2.65M in Q1 2014. 147 funds tracked by Wall St. Rank hold ANAC as of Q4 2014.

TFS Capital reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2014 after selling out during the quarter.
TFS Capital sold 17,684 ANACOR PHARMACEUTICALS INC COM shares in Q4 2014, an estimated $433K.
TFS Capital first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 4 quarters.
TFS Capital's ANACOR PHARMACEUTICALS INC COM position peaked at $2.65M in Q1 2014.
147 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2014.

Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.